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Abstract 
 
There is an extensive body of literature linking ADHD to overweight and obesity. Research 
indicates that impulsivity features of ADHD account for a degree of this overlap. The neural 
and polygenic correlates of this association have not been thoroughly examined. In 
participants of the IMAGEN study, we found that impulsivity symptoms and body mass 
index (BMI) were associated (r = 0.10, n = 874, p = 0.014 FWE corrected), as were their 
respective polygenic risk scores (PRS) (r = 0.17, n = 874, p = 6.5x10-6 FWE corrected). We 
then examined whether the phenotypes of impulsivity and BMI, and the PRS scores of 
ADHD and BMI, shared common associations with whole-brain grey matter and the 
Monetary Incentive Delay fMRI task, which associates with reward-related impulsivity. A 
sparse partial least squared analysis (sPLS) revealed a shared neural substrate that associated 
with both the phenotypes and PRS scores. In a last step, we conducted a bias corrected 
bootstrapped mediation analysis with the neural substrate score from the sPLS as the 
mediator. The ADHD PRS associated with impulsivity symptoms (b = 0.06, 90% CIs = 
0.001, 0.019) and BMI (b = 0.09, 90% CIs = 0.001, 0.023) via the neuroimaging phenotype. 
The BMI PRS associated with BMI (b = 0.014, 95% CIs = 0.003, 0.033) and impulsivity 
symptoms (b = 0.09, 90% CIs = 0.003, 0.022) via the neuroimaging substrate. A common 
neural substrate may (in part) underpin shared genetic liability for ADHD and BMI and the 
manifestation of their (observable) phenotypic association. 
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Introduction 
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a 
typically onset during childhood, but shows mixed patterns of continuity and remittance, 
along with adulthood onset1. Previous studies indicate an association between adult ADHD 
and being overweight and, in extremis, obesity2,3 – conditions which are relatively common 
and have marked long-term health effects4,5. Research has identified factors contributing to 
the comorbidity between ADHD and obesity, including fetal programming, psychosocial 
stress, and factors directly related to energy balance, reduced physical exercise and sleep 
patterns alterations6. The bulk of current research6 has focused on how neuropsychological 
impairments (e.g. impulsivity) associated with ADHD may increase dysregulated and 
excessive eating2,3. Importantly, neural and genetic liabilities may be important components 
underlying the phenotypic association between ADHD and overweight/obesity6.  
 With regard to neural correlates, a recent ADHD ENIGMA mega-analysis7 reported 
smaller subcortical volumes for ADHD (n = 20,183) compared to controls (n = 35,191) in the 
accumbens, amygdala, caudate nucleus, hippocampus and putamen. Importantly, some of 
these brain areas are involved in inhibitory control and reward-related pathways7. 
Neuroimaging studies in individuals who are overweight or obese have identified similar 
regions implicated in inhibitory control and reward-related pathways8, including the 
amygdala, hippocampus and prefrontal cortex as well sensory areas (precentral gyrus) that 
could relate to food cues9.  
Genome wide association studies (GWAS) have identified susceptibility loci for 
ADHD10 and obesity11. A polygenic risk score (PRS) – a cumulative genetic risk profile from 
across the genome – derived from the ADHD GWAS10 showed associations with obesity-
related indices of body mass index (BMI12), waist-to-hip ratio, childhood obesity, HDL 
cholesterol and Type 2 diabetes. Another study13 using the ADHD PRS reported positive 
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associations with BMI, depression and substance use, with an inverse relationship with 
numeric reasoning, suggesting genetic overlap with neurocognitive performance (see also14).  
Indeed, loci from the ADHD GWAS10 have been associated with both ADHD risk and lower 
intracranial volume, as well as the amygdala, caudate nucleus and putamen15.  
PRS approaches have also been applied to brain imaging studies. Although this has 
yet to be done with ADHD and obesity simultaneously, a PRS based on the recent ADHD 
GWAS10 associated with smaller caudate volume16. The use of PRS in schizophrenia has 
been associated with abnormalities in both brain structure17 and function18. With regard to 
structure, Neilson et al.17 reported an association with bilateral frontal gyrification, which is a 
hypothesized neural endophenotype of schizophrenia19.  
 These findings suggest that a better understanding of the relationship between ADHD 
and overweight/obesity may be gained by using an approach that incorporates both genetic 
and neural variation. We used the rich dataset of the ongoing IMAGEN study, comprising 
impulsivity symptoms, BMI, genome-wide loci and whole brain structural and functional 
neuroimaging measures at age 19. Firstly, we aimed to examine associations between PRS 
scores and phenotypes for ADHD and BMI, to assess genetic and phenotypic relationships 
between these traits. Secondly, we aimed to assess the associations between the PRS scores 
for ADHD and BMI, whole-brain structural variation, as well as a functional neuroimaging 
measure that assesses reward-related impulsivity. We were also interested in examining the 
degree to which the neuroimaging measures associated with the phenotypic measurements of 
impulsivity symptoms and BMI.  We had no a priori hypotheses about associations between 
the PRS scores and brain regions; we ran the analyses in an exploratory manner.  
 
Methods 
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Participants 
  We conducted all analyses on individuals drawn from the IMAGEN study 
(www.imagen-europe.com), a large-scale imaging genetic study aimed at identifying genetic, 
neuroimaging, and behavioral bases of individual variability in psychiatric disorders. Genetic 
data was derived from blood samples collected at the age of 14, while clinical, physical and 
neuroimaging data analysed in the present study were collected at the age of 19. Psytools 
software (Delosis Ltd, London, UK) was used to conduct the behavioral characterization via 
its internet-based platform. The assessment battery of questionnaires and cognitive tasks was 
self-administered both in participants' homes and at the neuroimaging facilities. The study 
was approved by local ethics research committees at each site. Written informed consent was 
obtained from all participants as well as from their legal guardians. 
Measures 
  Impulsivity symptoms at age 19 were assessed using self-reported scores taken from 
the well-validated Barratt Impulsivity Scale (BIS)20. The BIS is a questionnaire that is widely 
used to assess trait-impulsivity in a variety of studies including ADHD21, neuroimaging22, 
personality23, over-eating24 and in relation to genetic influence and criminal behaviors25. At 
the time the study was conducted, the IMAGEN consortium had BIS data for 1319 
individuals at 19 years-old.  
  Body mass index (BMI). BMI at age 19 was derived from height and weight 
measurements. Height was measured using a standard protocol to the last complete 
centimeter, weight was measured to the nearest 100 g. BMI was calculated as weight 
(kg)/height(m2). BMI values were recorded for 1347 subjects at the time the study was 
conducted. We excluded 114 participants who either were underweight (BMI < 18.5) 
extremely overweight (BMI >50).   
  Genetic data. After quality control, 1,982 cases were included in our sample totalling 
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506,932 SNPs available for PRS. Population stratification was controlled for in all analyses 
via the use of the first eight principal components of the genetic data, which were used as 
covariates. Full details on acquisition and initial processing are given in the supplementary 
materials of this paper.  
  MRI Data: In this investigation, we used voxel-based morphometry measures of grey 
matter derived from T1 weighted MRI acquisitions and activation maps derived from the 
Monetary Incentive Delay (MID) task, to examine neural responses to reward anticipation 
and reward outcome. Full details on the MRI acquisitions 26 pre-processing 27 and confounds 
used in the analysis are given in the Supplementary Material of this paper.  
  A Task Based fMRI Acquisition of the Monetary Incentive Delay (MID) task was used 
to examine neural responses to reward anticipation and reward outcome 28. The task consisted 
of 66 10-second trials. In each trial, participants were presented with one of three cue shapes 
(cue, 250 ms) denoting whether a target (white square) would subsequently appear on the left 
or right side of the screen and whether 0, 2 or 10 points could be won in that trial. After a 
variable delay (4,000-4,500 ms) of fixation on a white crosshair, participants were instructed 
to respond with left/right button-press as soon as the target appeared. Feedback on whether 
and how many points were won during the trial was presented for 1,450 ms after the 
response. Using a tracking algorithm, task difficulty (i.e. target duration varied between 100 
and 300 ms) was individually adjusted such that each participant successfully responded on 
~66% of trials. Based on prior research suggesting reliable associations between ADHD 
symptoms and fMRI blood-oxygen-level dependent (BOLD) responses measured during 
reward anticipation, the current study used the contrast ‘anticipation of high-win vs 
anticipation of no-win’.  
Statistical analyses 
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The analyses proceeded in three steps (code used in statistical analyses is available 
upon request). In Step 1, PRS scores were created for ADHD and BMI and we examined 
associations between the scores and phenotypic measures. We also calculated associations 
between the ADHD and BMI PRS scores themselves, in order to investigate a potential 
genetic comorbidity between ADHD and BMI. 
  To derive the ADHD PRS, summary statistics were downloaded from the Psychiatric 
Genomics Consortium (http://www.med.unc.edu/pgc/results-and-downloads; 20,183 cases 
and 35,191 controls, all European descent). To calculate the BMI PRS, GWAS summary 
statistics from 339,224 European descents were downloaded from the GIANT Consortium 
(http://portals.broadinstitute.org/collaboration/giant/index.php). Deriving a PRS necessitates 
the use of a significance threshold for inclusion of SNPs in the calculation of the score (e.g. 
all SNPs associated at p < 0.05). In investigations where the researcher is only interested in 
the relation between the score and the phenotype, it is possible to vary that threshold, and 
select that which results in the highest variance explained between the PRS and the 
phenotype29,30. However, in the present investigation, we were also interested in both the PRS 
scores themselves, and in their relation to functional and structural neuroimaging measures. 
In this case, varying the threshold for SNP inclusion in the PRS scores for ADHD and BMI, 
respectively, can lead to overfitting on the phenotype of interest30. Given the nature of our 
research question, which involves multiple phenotypes and multiple brain markers, this 
overfitting could lead to circularity problems in further analyses31. Using multiple PRS scores 
also poses a problem with multiple comparisons: if several PRS scores are calculated on the 
same phenotype, a correction must be carried out over these tests to ensure significance30. We 
therefore chose to use a nominal threshold of p = 0.05 for the inclusion of SNPs in the 
calculation of the score.  This approach avoids both overfitting and multiple testing. All 
genetic data processing and analyses were performed using the R package PRSice 15 and 
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PLINK 17. In order to minimise the statistical assumptions necessary for valid inference, all 
significance levels reported here were ascertained using permutation testing. As we are 
explicitly looking for comorbidities between different data types, and the sPLS analysis only 
identifies positive associations, all significance tests were one-sided. 
  In Step 2, we investigated whether ADHD and BMI share a common underlying 
neural substrate. We used a sparse formulation of partial least squares (sPLS) for this 
purpose18,19. This method is designed to establish associations between multiple sets of 
variables by finding the weighted sum of variables in each set, which correlate maximally 
with the weighted sum of variables that are connected via a path diagram (see Supplementary 
Figure S1). We used five-fold cross-validation to quantify the strength and significance of the 
associations of individual PRS scores and phenotypes, with the VBM and MID measures 
they were connected to via the path diagram32. 
  Although PLS methods are very powerful, results can be difficult to interpret, as all 
variables contribute to associations between data-views. This is particularly problematic with 
neuroimaging data, which is high dimensional. It would be useful to know which 
neuroimaging features were associated with PRS scores and phenotypes of impulsivity and 
BMI. For this reason, we used a method that induces sparsity by setting some PLS weights to 
zero through the application of an L1 penalty, applied under resampling
33,34. Through this 
approach, one can identify weighted sets of brain regions that are associated with the PRS 
scores and phenotypes. This set of brain regions may therefore be considered as an 
endophenotype for ADHD and BMI. We used a resampling procedure to ensure that the PLS 
approach only retained features that were robustly associated with phenotypes and genetic 
measures33. Significance was ascribed using a permutation testing procedure. A detailed 
description of the exact analysis approach used is detailed in the Supplementary Materials. In 
all analyses, we controlled for genetic population stratification (i.e. the 8 principle 
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components), gender, imaging site, age and total intracranial volume. Many association tests 
were carried out in this investigation. We corrected for multiple comparisons using the Holm-
Bonferroni method35.  
  In Step 3, we examined the degree to which the set of brain regions identified by PLS 
may act as an intermediary endophenotype between the PRS scores and the impulsivity and 
BMI phenotypes. In other words, we examined if the brain regions could help explain (or 
mediate) the observable association between ADHD and BMI genetic vulnerabilities and the 
impulsivity and BMI phenotypes. The mediation (or indirect) pathways were defined by the 
product term of the pathways of interest (e.g. PRS to brain BY brain to phenotype). There 
were four overall possible effects: 1) ADHD PRS  brain regions  impulsivity symptoms; 
2) ADHD PRS  brain regions  BMI; 3) BMI PRS brain regions  BMI; and 4) BMI 
PRS brain regions  impulsivity. Because standard errors underlying mediation pathways 
(i.e. the product terms) are known to be skewed, we bootstrapped all indirect effects 10,000 
times with bias corrected (90% and 95%) confidence intervals. The mediation pathways 
reported here are based on the bootstrapped variability around the product of non-
standardized path coefficient estimates (i.e. ‘b’). Mediation pathways were programmed in 
Laavan36 in the statistical package R37. 
Results 
  Step 1: PRS Scores for ADHD and BMI: At the time the study was conducted, n = 874 
subjects had complete genetic and phenotypic data. The BMI PRS score was significantly 
associated with BMI (r = 0.23, n = 874, p = 2.2x10-11 FWE corrected) and the PRS score for 
ADHD was significantly associated with impulsivity symptoms (r = 0.10, n = 874, p = 0.014 
FWE corrected). We also note that impulsivity symptoms were associated with BMI (r = 
0.10, n = 874, p = 0.014 FWE corrected), and that the PRS scores for ADHD and BMI were 
significantly cross-correlated (r = 0.17, n = 874, p = 6.5x10-6, FWE corrected). Of interest, 
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using Steiger’s test for dependent correlations38, we found that the correlation between the 
PRS scores of ADHD and BMI was higher (p = 0.036 FWE corrected) than the correlation 
between the phenotypic measures of impulsivity and BMI. 
  Step 2: The Shared Neural Correlates of the PRS Scores of ADHD and BMI: Of the 
874 subjects who had both complete genetic and phenotypic data, 604 had both T1 and fMRI 
data that passed QC. Using PLS, we found that both the ADHD and BMI phenotypes, and 
their respective polygenic risk scores, are significantly associated with a common neural 
substrate, constructed from T1 and fMRI data, which we term the ‘neural endophenotype’. 
The PRS for BMI was associated with the neural endophenotype at r = 0.12, n = 604, p = 
9.5x10-3, FWE corrected, whilst the ADHD PRS was significant at the level r = 0.087, n= 
604, p = 0.036 FWE corrected. ADHD and BMI phenotypes were also associated with this 
set of brain regions, with ADHD associated at r = 0.091, n = 604, p = 0.035 FWE corrected, 
and BMI associated at r = 0.15, n = 604, p = 9.0x10-4 FWE corrected respectively. These 
correlations are summarized in a matrix and path diagram in Figure 1. 
  The neural endophenotype is made up of grey matter regions and regions of activation 
derived from the MID task. Grey matter regions contributing to this neural endophenotype 
were located bilaterally in the cerebellum, amygdala, hippocampus, para-hippocampus and 
orbital frontal cortex, which all present bilaterally. There was also a largely left lateralised 
grey matter cluster in the inferotemporal cortex. PLS weights in each of these brain regions 
were negative, implying an inverse association between PRS scores/phenotypes and grey 
matter. Neural endophenotype clusters that came up in the MID task were largely left 
lateralised and included the fusiform gyrus and para-hippocampus, postcentral and parietal 
inferior, calcarine and occipital superior and frontal superior medial cortex. These results are 
displayed in Figure 2.  PLS weights in each of these brain regions were positive, implying a 
positive association between the MID contrast map and the PRS/phenotype scores. The full 
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set of VBM and MID clusters identified and localised in the sPLS analysis are tabulated in 
Supplementary Tables S1 and S2.  
  In Step 3, we saved the neuroimaging factor score from the sPLS and conducted the 
multivariate bias corrected bootstrapped mediation analyses. The four mediation pathways 
were observed, albeit at a 90% CIs for ADHD and 95% CIs BMI, suggesting that the neural 
endophenotype may act as an intermediary variable in the link between the PRS scores and 
the impulsivity and BMI phenotypes. These four mediation pathways were:  1) ADHD PRS 
 neuroimaging score  impulsivity (b = 0.06, 90% CIs = 0.001, 0.019); ADHD PRS  
neuroimaging score  BMI (b = 0.09, 90% CIs = 0.001, 0.023); 3) BMI PRS  
neuroimaging score  BMI (b = 0.014, 95% CIs = 0.003, 0.033); and 4) BMI PRS  
neuroimaging score  impulsivity (b = 0.09, 95% CIs = 0.001, 0.025). 
Discussion 
 
This study set out to examine if there are shared genetic and neural correlates of the ADHD 
(impulsivity) and BMI 39 phenotypes. Our results support previous ADHD-related research in 
showing an association between these two phenotypes3. Further analyses showed that the 
PRS scores for ADHD and BMI were correlated with each other and with grey matter across 
the brain and contrast maps derived from fMRI scans conducted during the MID task. 
Importantly, these neuroimaging measures also associated with the phenotypes of impulsivity 
and BMI. These results extend present knowledge of the biological origin of the association 
between ADHD and BMI phenotypes in three main ways. 
  Firstly, using previously established genome-wide evidence, and a multi-modal 
whole-brain approach, this study showed that The PRS scores and phenotypes of ADHD and 
BMI simultaneously associated with decreased in grey matter in brain reported by the case-
control ADHD ENIGMA mega-analysis7 as well as case-control designs of obesity9. These 
areas include the cerebellum, amygdala, hippocampus, orbitofrontal and inferotemporal 
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cortex. The functions of these brain areas underscore the importance of impairments in 
cognitive and behavioral control and impulsivity in both ADHD and BMI. For example, the 
fronto-cerebellar networks have been implicated in impairments of cognitive control (e.g. 
over-riding impulses) in both ADHD and obesity 40,41; the ability to consider future 
consequences/adjust behaviours 41; and the inhibition of eating behaviour 42. Likewise, the 
amygdala and hippocampus have been associated with impulsivity symptoms in ADHD 43 as 
well as weight gain and over-eating behaviours such as continuing to eat even when sated 44-
47. Finally, the orbital frontal cortex has been linked to impairments in cognitive and 
attentional control in ADHD 48, but also potentially to selection and consumption of calorie-
rich foods 49 and sensitized reactivity to (food-related) reward 50.  
  The second set of findings relate to the reward anticipation fMRI task. There was an 
increased BOLD response for the posterior visual and association areas, postcentral, 
cerebellum and frontal medial cortex. This was consistent with previous findings from both 
the MID task and other fMRI paradigms used to assess reward processes. With regard to the 
MID task, our findings converged with previous research that reported  abnormalities in 
frontal-parietal and cerebellar-parietal networks 51,52. Supporting other reward processing 
studies, we identified increased BOLD response in the cerebellum and postcentral gyri 47,53, 
in addition to reward areas in the medial frontal regions 54,55. Importantly, both the MID-
related results and previously mentioned grey matter results showed abnormalities in visual 
processing areas (i.e. inferotemporal and association cortices for grey matter and posterior 
visual and association cortices for the MID task). These abnormalities may be implicated in 
visual attention biases to reward-related cues (e.g.  food or reward) in both obesity and 
ADHD 37-39. 
 Third, we examined a multivariate mediation model. Here, the associations between 
the ADHD and BMI PRS scores and the impulsivity and BMI phenotypes were partially 
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carried by the brain areas identified by sPLS. We therefore suggest that these brain areas 
(structural + functional) may act as a neural endophenotype56 between the genetic liabilities 
of ADHD and obesity and the manifestation of their (observable) phenotypic association. By 
definition neurobiological endophenotypes mark genetic vulnerability but are also 
independent of disease state57. Our suggestion of a neural endophenotype is consistent with 
the idea that a limited number of neural systems may engender risk for a range comorbid 
psychiatric syndromes56. As such, this hypothesized “endophenotype” might extend as a 
latent vulnerability for known comorbidities of ADHD and BMI, such as substance use and 
addiction,58 and depression59,60, to name a few. 
   How might the results of the present study bear on future research? Are there 
(potential) clinical implications? It is important to note that our findings of genetic influence 
on ADHD and BMI are non-deterministic and can be context dependent61. Indeed, Barcellos 
et al.57, taking advantage of a natural experiment, showed that an additional year of 
compulsory schooling in the UK benefitted individuals with higher genetic risk for obesity, 
reducing the gap in unhealthy body size in the top and bottom terciles of genetic risk of 
obesity from 20 to 6 percentage points. This is an interesting result when it is considered that 
certain interventions targeting ADHD can result in weight reduction and, potentially, vice-
versa. Although findings are mixed, studies on Methylphenidate show that a reduction in 
ADHD symptoms can associate with decreased BMI, especially for overweight/obese 
adolescents3,62. Methylphenidate has also been proposed as a treatment for obesity63,64. Future 
research should examine if individuals at high genetic risk for both ADHD and BMI will 
especially benefit from interventions tailored for one – or both – of these conditions.  
  Our findings should be considered in light of a number of limitations. Firstly, our 
models were statistically driven - although theoretically informed. The models are therefore 
dependent on the properties of the measures included. While our PLS model identified 
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simultaneous association between the PRS scores, the two neuroimaging modalities and the 
phenotypic measurements of ADHD and BMI, this does not mean that this model – or the 
study variables contained within it – is the best (or only) solution. Secondly, it is also 
important to note that PRS and neural correlates only explain a small proportion of the 
liability for many psychiatric difficulties and other traits. Thirdly,  the current findings differ 
from reward anticipation in case-control ADHD designs65,66 and for clinical remission67. 
Relatedly, it will be of interest to replicate the present results in clinical samples, for ADHD 
and BMI separately, across different age groups, and across different ethnic groups. Fourth, 
in the mediation analyses, the ADHD-related pathway had larger bias corrected CIs (90%) 
compared to the BMI-related pathway (95%). There may be at least two reasons for these 
different CIs. The GWAS discovery sample for ADHD (n = 46,350) is smaller than BMI (n = 
339,224), which can differentially affect the predictive power of these PRS scores68. In 
addition, we examined the ADHD PRS in relation to impulsivity symptoms, which is less 
precise than examining the BMI PRS in relation to BMI.  
Conclusion 
Our results indicate that ADHD and BMI PRS scores are significantly correlated, suggesting 
shared genetic risk between the traits. In a data-driven model, both the PRS scores were 
associated with their respective phenotypic measures, as well as shared neural correlates of 
impairments in inhibitory control and reward processing. 
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Figure 1A: The panel on the left shows the path diagram illustrating associations between 
the different biological and phenotypic measures used in this investigation. Associations that 
are statistically significant are marked with an asterisk. B: The panel on the right shows 
correlation values between the different biological and phenotypic measures investigated in 
this study, the lower triangular matrix shows correlation values between the various 
biological measures, whilst the upper triangular matrix shows the FWE-corrected 
































Figure 2A: The scatter plots in panel A of the figure show relations between neuroimaging 
and ADHD and BMI PRS scores. B: The brain regions in panel B of the figure illustrate the 
VBM and MID regions that are associated with ADHD and BMI PRS scores, and their 
associated phenotypes. C: The scatter plots in panel C of the figure show relations between 
neuroimaging and ADHD and BMI phenotypes
 
 
 
